Recruitment Period means the period of 60 calendar days from the date on which the Divestiture Assets are divested to Acquirer.
Recruitment Period. Start: 07/SEP/2020 End: 01/MAR/2021 Principal Investigator Name: Xxxxxxxxx Xxxxxxx X’Brien Address: Department of Neurosciences, 4th Floor, Centre Block The Xxxxxx Hospital, 00 Xxxxxxxxxx Xxxx, Xxxxxxxxx Xxxxx: Xxxxxxxx, Xxxxxxxxx P/code: 3004 Reviewing HREC: Xxxxxx Health Human Research Ethics Committee Equipment provided by Sponsor: NIL Software provided by Sponsor: NIL Investigational Product: Dronabinol Acetazolamide
Recruitment Period. Start: / / End: / / Principal Investigator Name: Address: State: P/code: Responsible HREC: Equipment Provided by Organisation: Payments Text can be entered here Schedule 3 Study Protocol Identification Full Title: Version Number: Date: List of Key Arrangements: ………… Schedule 4 Special Conditions Text can be entered here [An alternative clause 12.2 that may be used: Clause 12.2 is replaced with the following: Intellectual Property developed jointly by the parties shall be owned by and is hereby assigned as the joint property of the parties as tenants in common. The ownership share of each party will be in proportion to that party's contribution to the development of the Intellectual Property. If the parties cannot agree on their respective ownership rights under clause A, this shall be resolved in accordance with the dispute resolution process set out in clause 14.]
Examples of Recruitment Period in a sentence
Enterprises benefiting from the incentives mentioned in the present Law are submitted to a follow-up and control of the competent administrative services.
The opening of the Continuous Recruitment Period date will be advertised in the New York State Contract Reporter.
Defendants’ obligations under this Paragraph I.4. will expire after the Recruitment Period.
In conjunction with the Panhellenic Association and the Interfraternity Council (IFC), the Office of Fraternity & Sorority Life will determine a Formal and Informal Recruitment Period during the fall and spring semesters.
For a period of one year from the date on which the Divestiture Assets are divested to Acquirer, Defendants may not solicit to rehire Relevant Personnel who were hired by Acquirer during the Recruitment Period, unless (a) an individual is terminated or laid off by Acquirer or (b) Acquirer agrees in writing that Defendants may solicit to rehire that individual.
More Definitions of Recruitment Period
Recruitment Period. Start: / / End: / / Principal Investigator Name: Address: State: P/code: Responsible HREC: Equipment Provided by Organisation: Payments Text can be entered here Schedule 3 Study Protocol Identification Full Title: Version Number: Date: List of Key Arrangements: ………… Schedule 4 Special Conditions Text can be entered here [An alternative clause 12.2 that may be used: Clause 12.2 is replaced with the following:
Recruitment Period means the period of time beginning with the posting of a notice of vacancy and ending with the completion of all tasks necessary to convene the commission. The recruitment period includes the application period.
Recruitment Period. (in studies where this is a relevant element -- state the date(s) during which or by which the recruitment is to be fully completed or refer to the Recruitment Plan, if there is such Plan)
Recruitment Period the sixty (60) day period during which the District recruits qualified applicants to fill a vacancy, beginning with the initial date the vacancy occurs. If the District recruits, a substitute may be employed in the vacancy.
Recruitment Period. Start: / / End: / / Principal Investigator Name: Address: State: P/code: Reviewing HREC: Equipment provided by Sponsor: Parties should write here if appropriate: “There is no investigational product” Software provided by Sponsor: Investigational Product: Studies in which there is no product: In Schedule 1, parties should write in the ‘Investigational Product’ field: “There is no Investigational Product being used in this Study”. Because the definition of Investigational Product (in Clause 1 ‘Interpretation’) refers directly to the description in Schedule 1, entering such a description renders all obligations relating to Investigational Product in the body of the CTRA to automatically fall silent. Schedule 2 Payments In accordance with clause 6.1, parties should use Schedule 2 to describe “the manner” in which the Sponsor will pay the Institution (ie/ through a third party payor). Institutions should ensure that invoices are made out to the Sponsor (with whom they have a contract) and sent “care of” the payor (who will pay the invoice). Please paste/enter text below; delete this instruction and the suggested subject matter list once the payment schedule has been included. Suggested High Level Subject matter
Recruitment Period. Start: / / End: / / Principal Investigator Name: Address: State: P/code: Investigational Product: Responsible HREC: Equipment Provided by Sponsor: Payments Text can be entered here Schedule 3 Form of Indemnity for Clinical Trials (to be inserted by Sponsor) The Sponsor agrees to execute and deliver to the Institution, as necessary, an indemnity in the form of the Medical Technology Association of Australia Standard Form of Indemnity for Clinical Investigations without amendment. Text can be entered here Schedule 4 Insurance Arrangements (to be inserted by Sponsor) Certificate of Insurance For a Study to be conducted in Victoria, the following details are mandatory; Insurance provider Insured Entity Additional Insured Clinical Investigation Plan/ CTN number Limits of Liability in AUD/ Per occurrence amount and Annual Aggregate Excess/ deductible/ Self insured risk Victorian Managed Insurance Authority Guidelines can be found at the VMIA website in the ‘Clinical Trials’ section under ‘Public Healthcare’: xxxx://xxx.xxxx.xxx.xxx.xx/ For a Study to be conducted in any other State in Australia, the relevant insurance requirements within those States will be adhered to and documented in this Schedule. Text can be entered here Schedule 5 Guidelines for Compensation for Injury Resulting from Participation in a Company-Sponsored Clinical Investigation (Or include website address) Text can be entered here Schedule 6 Clinical Investigation Plan Identification Full Title: Version Number: Date: List of Key Attachments: Schedule 7 Special Conditions Text can be entered here Clinical Investigation Plan Number: Site: Commercially Sponsored Clinical Investigation Research Agreement: 29 March 2010 Page 24 of 24
Recruitment Period. “Nábor” “Regulations” All laws, rules, regulations and guidelines that apply to or govern the conduct of the multi-centre Clinical Trial and/or the Clinical Trial, including without limitation the applicable ICH guidelines (including E6: Good Clinical Practice: Consolidated Guideline, and the ICH Harmonised Tripartite Guideline for Good Clinical Practice (CHMP/ICH/135/95; hereinafter: “GCP”), together with the requirements in Clinical Trial Directive 2001/20/EC (4 April 2001) and the related guidance, guidelines and directives), the most recent version of Standard BS EN ISO 14155, the World Medical Association Declaration of Helsinki entitled ‘Ethical Principles for Medical Research Involving Human Subjects’ (“Helsinki Declaration”), all relevant laws of the European Union if directly applicable or of direct effect, all national laws and all relevant regulations and ordinances such as Act No. 378/2007 Coll., on Pharmaceuticals, as amended and the Regulation No. 226/2008 Coll., on Good Clinical Practice, as amended and all relevant laws and regulations regarding data protection and privacy, especially the Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 - General Data Protection Regulation or “GDPR” and Act No. 110/2019 Coll. on the Processig of Personal Data (together: “Data Processing Laws”) and anti-bribery and ethical business conduct, and the requirements of the applicable regulatory authorities and the ethics committee and the policies of the INSTITUTION, as any of the foregoing may be amended from time to time, including the Clinical Trial Regulation EU „Předpisy” Všechny zákony, pravidla, předpisy a směrnice, které se týkají nebo upravují průběh multicentrického klinického hodnocení a/nebo Klinického hodnocení, mimo jiné včetně platných směrnic ICH (včetně E6: Správná klinická praxe: Konsolidovaná směrnice a tripartitní harmonizovaná směrnice ICH pro správnou klinickou praxi (CHMP/ICH/135/95; dále jen: „GCP“) spolu s požadavky uvedenými ve Směrnici o klinickém hodnocení 2001/20/ES (4. dubna 2001) a souvisejícími radami, pokyny a směrnicemi), v nejaktuálnější verzí normy BS EN ISO 14155, v Helsinské deklaraci Světové lékařské asociace nazvané „Etické zásady pro lékařský výzkum na člověku“ („Helsinská deklarace“), ve všech příslušných zákonech Evropské unie, pokud se přímo uplatí nebo mají přímý účinek, ve všech vnitrostátních zákonech a všech příslušných předpisech a vyhláškách, jako je zákon č. 378/2007 Sb., o ...